ArticleWorld journal of clinical oncology2018

Current status of PI3K-mTOR inhibition in hormone-receptor positive, HER2-negative breast cancer.

Navid Sobhani et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.